Sie befinden sich hier
Inhalt
GRK 2727 students obtain additional valuable input to their thesis projects during lab-visits, workshops and joint thesis advisory committee (TAC) meetings with pioneers in the field of innate immunity from the Karolinska Institute (KI) in Stockholm and from Vienna University. The Karolinska Institute has a long history of pioneering the field of NK cell research. In Stockholm, GRK 2727 collaborates with the educational program of Cancer Research at KI (https://ki.se/en/cancerresearchki/cancer-research-ki-research-training). In Vienna, Prof. Veronika Sexl/Prof. Mathias Müller/Dr. Dagmar Gotthardt coordinate the collaborations providing complimentary expertise in both myeloid cell and NK cell signal transduction. Several of the Vienna collaborators are members of the Vienna JAK/STAT Consortium (https://jak-stat.at/ FWF-funded; spokesperson Prof. Mathias Müller).

Center for Infectious Medicine
Department of Medicine

Department of Microbiology, Tumor and Cell Biology

Institute of Pharmacology and Toxicology, Department of Biomedical Sciences

Department of Biomedical Sciences, Institute of Animal Breeding and Genetics

Institute of Pharmacology and Toxicology, Department of Biomedical Sciences
Kontextspalte
GRK 2727/1 – InCheck
„Innate Immune Checkpoints in Cancer and Tissue Damage"
TPMA2, 2. OG
Franz-Volhard-Str. 6
68167 Mannheim
Phone +49 621 383-71509
Fax +49 621 383-71506
grk2727@ medma.uni-heidelberg.de
Twitter GRK 2727: @grk2727